Equity Overview
Price & Market Data
Price: $0.0186
Daily Change: $0.00 / 0.00%
Range: $0 - $0
Market Cap: $7,534,151
Volume: 0
Performance Metrics
1 Week: 19.89%
1 Month: 31.18%
3 Months: 227.0%
6 Months: 254.0%
1 Year: 38.00%
YTD: 346.0%
Details
Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It develops Bucillamine, a disease-modifying anti-rheumatic drug, for the treatment of infectious diseases, including influenza and COVID-19, as well as to treat pandemic influenza, emerging infectious diseases, and medical countermeasure incidents and attacks. The company also develops Psilocybin that is in Phase 1 clinical study for treating methamphetamine use disorder; and Psilocin for the treatment of depression, anxiety, bi-polar disorder, bulimia and anorexia nervosa, and other diseases. Revive Therapeutics Ltd. is based in Toronto, Canada.